Short communicationSyntheses of Nα-(β-naphthylsulfonylaminoglycyl)-argininamide (cas 16709-23-2)s as potential selective synthetic thrombin inhibitorsSynthèses de Nα-(β-naphthylsulfonylaminoglycyl)-argininamide (cas 16709-23-2)s, inhibiteurs potentiels sélectifs de la thrombine synthétiques
-
Add time:09/24/2019 Source:sciencedirect.com
This paper deals with the synthesis of Nα-(β-naphthylsulfonylaminoglycyl)-argininamide compounds and the results of a pharmacological study (in vitro and in vivo). No thrombin inhibition was obtained with Nα-arylsulfonyl-aminoalkyl-(4-amidinophenyl)-alaninamide compounds in which the 4-amidinophenylalanyl residue was substituted by an arginyl residue.
We also recommend Trading Suppliers and Manufacturers of argininamide (cas 16709-23-2). Pls Click Website Link as below: cas 16709-23-2 suppliers
Prev:NG-Acyl-argininamide (cas 16709-23-2)s as NPY Y1 receptor antagonists: Influence of structurally diverse acyl substituents on stability and affinity
Next:Design and automated production of 11C-ALPHA-METHYL-L-TRYPTOPHAN (cas 16709-25-4) (11C-AMT)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- NG-Acyl-argininamide (cas 16709-23-2)s as NPY Y1 receptor antagonists: Influence of structurally diverse acyl substituents on stability and affinity09/10/2019
- Regular articleSolution structure of the HIV-2 TAR-argininamide (cas 16709-23-2) complex1☆09/09/2019
- l-argininamide (cas 16709-23-2) improves the refolding more effectively than l-arginine09/08/2019
- Red-fluorescent argininamide (cas 16709-23-2)-type NPY Y1 receptor antagonists as pharmacological tools09/07/2019
- Dimeric argininamide (cas 16709-23-2)-type neuropeptide Y receptor antagonists: Chiral discrimination between Y1 and Y4 receptors09/06/2019


